實驗室資訊學的全球市場：市場規模和佔有率分析（依產品、交付模式和組件）、工業需求預測（截至 2030 年）

2023年全球實驗室資訊學市場價值為43.762億美元，2024-2030年複合年增長率為11.4%，到2030年達到91.766億美元。產業成長很大程度上與實驗室自動化需求的快速成長以及生物樣本庫/生物樣本庫以及生物技術和製藥產業研發支出的增加有關。

基於雲端的品類引領市場

從交付方式來看，到 2023 年，基於雲端的類別將佔據最大佔有率，達到 55%，而這一趨勢預計將持續下去。

北美是最賺錢的

從地區來看，北美將在 2023 年以 40% 左右的佔有率引領該行業，並預計到本十年末將實現強勁增長。最先進的 IT 基礎設施、高數位素養以及支援實驗室資訊系統接受的立法是產業成長的關鍵驅動力。

此外，不斷上漲的醫療保健成本和控製成本的需要促使整個行業使用 LIMS。此外，成熟製藥公司的存在以及控制與資訊管理和分析相關的營運成本的日益增長的需求是行業擴張的主要驅動力。

在本報告中，我們分析了全球實驗室資訊學市場，包括市場的基本結構、最新情況、主要促進和抑制因素以及全球、依地區和主要國家的市場規模前景（數量/價值）基礎，2017年-2030年），依產品、交付模式、零件和行業劃分的詳細趨勢、當前市場競爭狀況以及主要公司簡介。

目錄

第一章 調查範圍

第二章研究方法

第3章執行摘要

第四章 市場指標

第五章 產業展望

• 市場動態
  • 趨勢
  • 促進因素
  • 抑制因素/課題
  • 促進/抑制因素影響分析
• 新型冠狀病毒感染（COVID-19）的影響
• 波特五力分析

第六章 世界市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依交付模式分類（2017-2030）
• 市場收入：依組成部分（2017-2030）
• 市場收入：依行業分類（2017-2030）
• 市場收入：依地區（2017-2030）

第七章 北美市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依交付模式分類（2017-2030）
• 市場收入：依組成部分（2017-2030）
• 市場收入：依行業分類（2017-2030）
• 市場收入：依國家分類（2017-2030）

第八章歐洲市場

第九章亞太市場

第十章 拉丁美洲市場

第十一章 中東和非洲（MEA）市場

第十二章 美國市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依交付模式分類（2017-2030）
• 市場收入：依組成部分（2017-2030）
• 市場收入：依行業分類（2017-2030）

第十三章 加拿大市場

第十四章 德國市場

第十五章 法國市場

第十六章 英國市場

第十七章 義大利市場

第十八章 西班牙市場

第十九章 日本市場

第20章 中國市場

第21章 印度市場

第22章澳洲市場

第23章 韓國市場

第24章 巴西市場

第25章 墨西哥市場

第26章 沙烏地阿拉伯市場

第27章南非市場

第28章 阿拉伯聯合大公國（UAE）市場

第29章競爭格局

• 市場參與者及其提供的產品/服務的列表
• 主要企業競爭基準
• 主要公司的產品基準
• 近期策略發展狀況

第三十章 公司簡介

• LabVantage Solutions Inc.
• Thermo Fisher Scientific Inc.
• STARLIMS Corporation
• PerkinElmer Inc.
• LABWORKS LLC
• Autoscribe Informatics
• Dassault Systemes SE
• Agilent Technologies Inc.
• Cerner Corporation
• McKesson Corporation

第31章附錄

The laboratory informatics market had a size of USD 4,376.2 million in 2023, which will power at a compound annual growth rate of 11.4% by 2024- 2030, touching USD 9,176.6 million by 2030. The industry growth has a lot to do with the surge in the demand for lab automation, along with biobanks/biorepositories and an increase in research and development spending in the biotech and pharma sectors.

Growth Drivers

The increase in the demand for lab automation will power the acceptance of these systems. Owing to the fast enhancements in molecular genomics and genetic testing procedures, the data produced by labs has quickly increased.

Also, the requirement for automated lab systems will increase as a result of the shift in the preference in the direction of personalized care, increase in numerous cancer genomics investigations, and development in patient engagement needs.

The industry will benefit from the governing authorities' snowballing pressure for the disposition of lab automation systems.

Healthcare processes have turned out to be reproducible and repeatable with the mounting acceptance of process automation and robotics.

The growing usage of high-output technologies has made it likely to assess experimental results more competently, which advances the general efficiency of laboratory operations.

The ECM Category has the Fastest Growth

The ECM category will grow the fastest in the years to come, with a 12% rate in the industry.

The acceptance of ECM is growing as it provides comprehensive and integrated solutions for meeting the rising issues in the healthcare sector.

ECM provides a centralized method for seizing, making, organizing, accessing, and examining the whole ecosystem of knowledge assets, media, and e-documents in a company.

Moreover, companies in the industry offer more than a few services associated with ECM, such as design, consultation, installation, and upkeep of these software solutions.

Cloud-Based Category Leads the Market

On the basis of delivery mode, the cloud-based category had the largest share of 55%, in 2023, and it will continue like this in the years to come as well.

This is for the reason that cloud-deployed LIMs make available space on on-premises computer devices, by stowing vast data amounts offsite, which likewise makes it easier for retrieving it whenever the client requires it.

Cloud-based LIMs can be availed of in three ways, PaaS, IaaS, and SaaS. On the SaaS platform, IBM offers its Watson Analytics services. Additionally, LabVantage Solutions Inc. and Core Informatics provide cloud-based services for LIMS.

North America Makes the Most Revenue

North America leads the industry with about 40% share, in 2023, and it will power at a robust rate by the end of this decade. The accessibility of cutting-edge IT infra, together with high levels of digital literacy and legislation boosting the acceptance of lab information systems, is the key driver for the growth of the industry.

Furthermore, the growing healthcare expenditures and the necessity to stem this surge have brought about the usage of LIMSs across industries. Additionally, the existence of well-established pharma businesses and the mounting requirement to control operational costs associated with info management and analysis are the main drivers for the expansion of the industry.

Competitive Analysis

With an increase in the requirement for COVID-19 tests, clinical labs extended the degree of their operations. In turn, the large number of patients led to challenges in emerging, regulating, and validating novel approaches for testing patients, along with gathering, stowing, examining, and rapidly and precisely reporting massive volumes of patient test data.

LIM is important for coping with the requirement for COVID-19 tests in clinical labs, which encouraged product acceptance during the outbreak of the pandemic.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by delivery mode
  • 1.4.3. Market size breakdown, by component
  • 1.4.4. Market size breakdown, by industry
  • 1.4.5. Market size breakdown, by region
  • 1.4.6. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Delivery Mode (2017-2030)
• 6.4. Market Revenue, by Component (2017-2030)
• 6.5. Market Revenue, by Industry (2017-2030)
• 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Delivery Mode (2017-2030)
• 7.4. Market Revenue, by Component (2017-2030)
• 7.5. Market Revenue, by Industry (2017-2030)
• 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Delivery Mode (2017-2030)
• 8.4. Market Revenue, by Component (2017-2030)
• 8.5. Market Revenue, by Industry (2017-2030)
• 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Delivery Mode (2017-2030)
• 9.4. Market Revenue, by Component (2017-2030)
• 9.5. Market Revenue, by Industry (2017-2030)
• 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Delivery Mode (2017-2030)
• 10.4. Market Revenue, by Component (2017-2030)
• 10.5. Market Revenue, by Industry (2017-2030)
• 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Delivery Mode (2017-2030)
• 11.4. Market Revenue, by Component (2017-2030)
• 11.5. Market Revenue, by Industry (2017-2030)
• 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Delivery Mode (2017-2030)
• 12.4. Market Revenue, by Component (2017-2030)
• 12.5. Market Revenue, by Industry (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Delivery Mode (2017-2030)
• 13.4. Market Revenue, by Component (2017-2030)
• 13.5. Market Revenue, by Industry (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Delivery Mode (2017-2030)
• 14.4. Market Revenue, by Component (2017-2030)
• 14.5. Market Revenue, by Industry (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Delivery Mode (2017-2030)
• 15.4. Market Revenue, by Component (2017-2030)
• 15.5. Market Revenue, by Industry (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Delivery Mode (2017-2030)
• 16.4. Market Revenue, by Component (2017-2030)
• 16.5. Market Revenue, by Industry (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Delivery Mode (2017-2030)
• 17.4. Market Revenue, by Component (2017-2030)
• 17.5. Market Revenue, by Industry (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Delivery Mode (2017-2030)
• 18.4. Market Revenue, by Component (2017-2030)
• 18.5. Market Revenue, by Industry (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Delivery Mode (2017-2030)
• 19.4. Market Revenue, by Component (2017-2030)
• 19.5. Market Revenue, by Industry (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Delivery Mode (2017-2030)
• 20.4. Market Revenue, by Component (2017-2030)
• 20.5. Market Revenue, by Industry (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Delivery Mode (2017-2030)
• 21.4. Market Revenue, by Component (2017-2030)
• 21.5. Market Revenue, by Industry (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Delivery Mode (2017-2030)
• 22.4. Market Revenue, by Component (2017-2030)
• 22.5. Market Revenue, by Industry (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Delivery Mode (2017-2030)
• 23.4. Market Revenue, by Component (2017-2030)
• 23.5. Market Revenue, by Industry (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Delivery Mode (2017-2030)
• 24.4. Market Revenue, by Component (2017-2030)
• 24.5. Market Revenue, by Industry (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Delivery Mode (2017-2030)
• 25.4. Market Revenue, by Component (2017-2030)
• 25.5. Market Revenue, by Industry (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Delivery Mode (2017-2030)
• 26.4. Market Revenue, by Component (2017-2030)
• 26.5. Market Revenue, by Industry (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Delivery Mode (2017-2030)
• 27.4. Market Revenue, by Component (2017-2030)
• 27.5. Market Revenue, by Industry (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Delivery Mode (2017-2030)
• 28.4. Market Revenue, by Component (2017-2030)
• 28.5. Market Revenue, by Industry (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. LabVantage Solutions Inc.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Thermo Fisher Scientific Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. STARLIMS Corporation
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. PerkinElmer Inc.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. LABWORKS LLC
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Autoscribe Informatics
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Dassault Systemes SE
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Agilent Technologies Inc.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Cerner Corporation
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. McKesson Corporation
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports